In France, approximately 4.5 million people live with diabetes, and each year, nearly 80,000 new cases of diabetic foot ulcers are reported. Nearly 25% of diabetics will one day face this type of complication, which is often insidious and difficult to detect.
Without prompt and appropriate treatment, these conditions can lead to amputations, which in 85% of cases are related to infected wounds.
Thanks to continuous monitoring of plantar temperature, it has been scientifically proven that more than 80% of complications* related to diabetic foot can be prevented.
*Lavery LA, Armstrong DG. Unilateral remote temperature monitoring to predict future ulceration for the diabetic foot in remission. BMJ Open Diabetes Res Care. 2019
Our medical device, designed in collaboration with healthcare professionals, consists of a pair of connected insoles that continuously measure variations in the patient plantar temperature.
The collected data are transmitted to patients and healthcare professionals via dedicated applications, enabling tailored care to be provided in relation to diabetic foot complications.
Medical device currently undergoing certification for use by diabetic patients. For more information, ask your doctor for advice. Please read the instructions carefully before use.
From a scientific and clinical perspective, the medical device is based on scientific publications as well as recent recommendations from the International Working Group on the Diabetic Foot (IWGDF).
Partnership with research centers and recognized experts: The solution was developed in collaboration with university hospitals (CHUs), as well as diabetologists, podiatrists, and biomechanists specializing in the diabetic foot, who are members of the Diabetic Foot Group of the Francophone Diabetes Society (SFD).
Worldwide, there are 680 million diabetics, and nearly 25% of them will experience foot complications during their lifetime.
En Europe, sur les 60 millions de patients diabétiques, chaque année plus de 1 million développent un foot ulcer diabetic, and 250,000 suffered amputations.
In France, among 4.5 million people with diabetes, there are 80,000 cases of diabetic foot ulcers each year.
The onset of these ulcers must be monitored with the utmost vigilance, as they often go unnoticed and progress silently. It is therefore very important to react as quickly as possible and to receive appropriate care in order to prevent complications (infected wounds, ulcers, amputations).
Following an initial ulcer, the recurrence rate is very high: 35% risk of recurrence in the following year, and up to 65% within 5 years.
Detecting the risk of infection and ulceration is becoming a major problem for diabetic patients, and the consequences can be serious since
Our medical device provides continuous remote monitoring of changes in patients' foot temperatures. Thanks to a secure platform, patients and healthcare professionals receive essential data and alerts instantly, enabling proactive care and accurate, effective medical monitoring.
Thin and flexible, our technical insole can be easily integrated into all types of foot orthotics without requiring any modifications or complex adjustments by podiatrists. It offers a simple and effective solution that combines technology and comfort for optimal patient care.
Thanks to its operating principle, which requires no recharging, our connected insole ensures continuous monitoring with ease. By facilitating compliance and raising patients' awareness of the early signs of foot ulcers, it actively involves them in their care for better prevention and therapeutic adherence.
The Solsius SelfCare application works exclusively with Solsius SelfCare connected insoles.
Thanks to the application, you can benefit from personalised monitoring :
Download
Available free on the App Store (iOS) and Google Play (Android).
